|
Volumn 38, Issue 10, 2006, Pages 3564-3566
|
Outcome of Imported Liver Allografts and Impact on Patient Access to Liver Transplantation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
BILIRUBIN;
HEPATITIS B ANTIBODY;
HEPATITIS C ANTIBODY;
INOTROPIC AGENT;
LIVER ENZYME;
ADULT;
ALLOGRAFT;
ANAMNESIS;
ARTICLE;
BLEEDING;
CONTROLLED STUDY;
GRAFT RECIPIENT;
GRAFT SURVIVAL;
HUMAN;
HYPERNATREMIA;
INFECTION;
LIVER DISEASE;
LIVER GRAFT;
LIVER GRAFT REJECTION;
LIVER TRANSPLANTATION;
MAJOR CLINICAL STUDY;
MEDICAL RECORD REVIEW;
ORGAN DONOR;
POSTOPERATIVE COMPLICATION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SCORING SYSTEM;
SEROLOGY;
SURVIVAL TIME;
SYSTEMIC DISEASE;
TREATMENT OUTCOME;
HEPATITIS C;
HUMANS;
LIVER TRANSPLANTATION;
PATIENT SELECTION;
REOPERATION;
RETROSPECTIVE STUDIES;
TISSUE DONORS;
TRANSPLANTATION, HOMOLOGOUS;
TREATMENT OUTCOME;
|
EID: 33845437999
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2006.10.037 Document Type: Article |
Times cited : (4)
|
References (9)
|